Integrated ‘omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 289, 1-13
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Mitochondrial DNA methylation as a next-generation biomarker and diagnostic toolMolecular Genetics and Metabolism, 2013
- A role for sequestosome 1/p62 in mitochondrial dynamics, import and genome integrityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2013
- Pattern discovery and cancer gene identification in integrated cancer genomic dataProceedings of the National Academy of Sciences, 2013
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- ConsensusPathDB: toward a more complete picture of cell biologyNucleic Acids Research, 2010
- ToppCluster: a multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systemsNucleic Acids Research, 2010
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genomeGenome Biology, 2009
- Development of Hepatocellular Carcinoma in Iqgap2-Deficient Mice Is IQGAP1 DependentMolecular and Cellular Biology, 2008
- Contribution of CYP2C9, CYP2A6, and CYP2B6 to Valproic Acid Metabolism in Hepatic Microsomes from Individuals with the CYP2C9*1/*1 GenotypeToxicological Sciences, 2006
- Differential effect of valproate and its Δ2- and Δ4-unsaturated metabolites, on the β-oxidation rate of long-chain and medium-chain fatty acidsChemico-Biological Interactions, 2001